Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

Walgreens Boots Alliance ( WBA 1.03%) and CVS Health ( CVS 2.86%) face uncertain paths forward. They have both undergone ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc ... organ transplants and other conditions and procedures, the FTC said. The report demonstrates how pharmacy benefit ...

Evercore ISI raised the firm’s price target on CVS Health (CVS) to $65 from $60 and keeps an Outperform rating on the shares. Given 2025 will ...

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...

Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...

Instead of waiting for an employee to take pity on you and unlock the cabinets in the deodorant aisle, you may soon have ...